Redcliffe Lifetech raises Rs 466 crore to expand access to diagnostic tests across India
"Redcliffe's vision of shifting healthcare from treating the sick to enabling wellness will have profound implications for millions," LeapFrog Investments Partner and Global Co-Leader for Health Investments Biju Mohandas said.
New Delhi: Leading diagnostics platform Redcliffe Lifetech on Friday said it has raised USD 61 million (around Rs 466 crore) in a funding round led by LeapFrog Investments. Healthquad, Schroders, LC Nueva, Growth Spark Ventures and existing investors Chiratae Ventures and Alkemi Venture Partners also participated in the funding round.
The investment will be used to expand its geographic reach across the country, with a focus on expanding its low-cost high quality direct-to-consumer diagnostics, into tier 2, 3 and 4 cities, the company said in a statement.
The latest funding will also be used to scale its platform and increase its product offerings to radiology, disease data profiling and lifestyle management, furthering its mission to shift India's healthcare focus from treatment to early diagnosis and prevention, it added.
"Preventative medicine is the future of health in India, helping to empower the average Indian with the information they need to take charge of their health and wellbeing," Redcliffe Founder Dheeraj Jain noted.
The company has built a one-stop diagnostic shop offering a very wide selection of tests to choose from and delivering care closer to the customer and the fresh investment will help to scale up rapidly to achieve the goal to reach over 50 crore Indians within the next five years, he added.
"Redcliffe's vision of shifting healthcare from treating the sick to enabling wellness will have profound implications for millions. We're thrilled to be partnering with Dheeraj and his management team to further scale their reach across India," LeapFrog Investments Partner and Global Co-Leader for Health Investments Biju Mohandas said.
Redcliffe currently has a network of 22 laboratories across 14 cities in the country.
Read also: Redcliffe Labs plans to strengthen team, to hire over 1000 employees
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.